ClinicalTrialsFinder

Real World Study Clinical Trials in Shenzhen, Guangdong

1 recruitingShenzhen, Guangdong, China

Showing 1–1 of 1 trials

Recruiting

Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib

Non-small Cell Lung CancerReal World StudyObservational Study+3 more
Peking University Shenzhen Hospital20 enrolled1 locationNCT07374614